Inhibition of EphA4 signaling slowed down disease onset and/or progression, and improved motor function in rodent models for ALS by reducing the vulnerability of motor neurons and enhancing NMJ innervation (Van Hoecke et al., 2012). The gene discussed is EPHA4; the disease is amyotrophic lateral sclerosis.